Radiation Oncology/Therapy: Page 97

Varian wins German proton therapy contract
By AuntMinnieEurope.com staff writers
Radiation therapy firm Varian Medical Systems said it has won an installation of its intensity-modulated proton therapy (IMPT) system at a Munich-based cancer clinic.
December 13, 2010
IOERT successful as boost during breast conservation surgery
By Cynthia E. Keen
Breast cancer patients undergoing breast conservation surgery who have an intraoperative electron radiation therapy (IOERT) boost followed by whole-breast irradiation have a much lower rate of cancer recurrence 10 years after treatment, according to a study presented at the San Antonio Breast Cancer Symposium.
December 13, 2010
Brachytherapy good option for younger prostate cancer patients
By Reuters Health
NEW YORK (Reuters Health) - Brachytherapy is a viable option for prostate cancer patients 60 years and younger, researchers from University Medical Center Utrecht in the Netherlands conclude in a new report in BJU International.
December 8, 2010
Reuterslogo
Diabetes, obesity worsen breast cancer outcomes
By Reuters Health
NEW YORK (Reuters Health) - Poor breast cancer outcomes in women with diabetes and obesity are linked to hyperinsulinemia, new research suggests. The research is reported in five separate papers, all published online November 29 in the Journal of Clinical Oncology.
December 5, 2010
Reuterslogo
Elekta wins Calif. contract
By AuntMinnieEurope.com staff writers
Swedish oncology firm Elekta announced installation of a full suite of its oncology products at the Roy and Patricia Disney Family Cancer Center, scheduled to open in February 2011 at the Providence Saint Joseph Medical Center in the San Fernando Valley.
December 1, 2010
Varian installs linac in Bulgaria
By AuntMinnieEurope.com staff writers
Radiation therapy firm Varian Medical Systems has installed its RapidArc-equipped Clinac iX linear accelerator at Queen Giovanna University Hospital in Sofia, Bulgaria, the company announced.
November 29, 2010
Mirada adds Oncology Fusion to Vitrea Enterprise Suite
By AuntMinnieEurope.com staff writers
Medical imaging software developer Mirada Medical announced its Oncology Fusion XD3 multimodality image fusion analysis package is now available as a fully integrated option with the Vitrea Enterprise Suite from advanced visualization firm Vital Images.
November 28, 2010
Less invasive lung cancer staging strategy has multiple benefits: study
By Reuters Health
NEW YORK (Reuters Health) - Initiating mediastinal nodal staging of suspected lung cancer with endosonography, followed by surgical staging (mediastinoscopy) if needed, improves the detection of metastases and reduces the rate of unnecessary thoracotomies, compared with surgical staging alone.
November 23, 2010
Reuterslogo
Risk of later CNS tumors after childhood cancer increases with radiation dose
By Reuters Health
NEW YORK (Reuters Health) - The risk of second primary neoplasms of the central nervous system (CNS) in survivors of childhood cancer increases greatly with the dose of radiation they received and, independently, with the dose of intrathecal methotrexate used.
November 15, 2010
Reuterslogo
Adjuvant WBRT for metastases improves neither survival nor independence
By Reuters Health
NEW YORK (Reuters Health) - Whole-brain radiotherapy (WBRT) following surgery or radiosurgery of some brain metastases reduces intracranial relapses and neurologic deaths, but it doesn't improve overall survival or the duration of functional independence.
November 11, 2010
Reuterslogo
Chemo + radiation may save cancerous bladders
By Reuters Health
NEW YORK (Reuters Health) - Treatment with chemotherapy plus radiation therapy is a viable alternative to radical surgery in some patients with muscle invasive bladder cancer, according to presentation at Monday's plenary session of the American Society for Radiation Oncology annual meeting.
November 3, 2010
Reuterslogo
Pre-op RT improves rectal cancer outcomes
By Reuters Health
NEW YORK (Reuters Health) - A short course of radiation therapy (RT) prior to total mesorectal excision for rectal cancer cuts the long-term risk of recurrence in half, according to data presented at this week's American Society for Radiation Oncology (ASTRO) meeting in San Diego.
November 2, 2010
Reuterslogo
Previous Page
Page 97 of 127
Next Page